瑞BNT 162b2 COVID-19疫苗诱发的发性心肌炎:一个案例研究
Natalie L Montarello1,2, Hao Zheng Wong3, Ashlee Jeffries1
1Department of Cardiology, The Royal Adelaide Hospital, Adelaide, South Australia, Australia.
概括
由于mRNA COVID-19疫苗引起的 fulminant myopericarditis的罕见病例可能会危及生命. 在这种情况下,早期的机械辅助与静脉外体膜氧化和免疫球蛋白治疗改善了临床结果.
科学领域:
- 心脏病学 心脏病学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- mRNA COVID-19 疫苗与罕见的 fulminant 心肌炎病例有关.
- 心肌瘤炎,特别是发性形式,具有重大,危及生命的风险.
研究的目的:
- 在mRNACOVID-19疫苗接种后报告发性心肌炎的病例.
- 突出早期机械循环支持和免疫球蛋白治疗的治疗益处.
主要方法:
- 病例报告详细介绍了患有严重心肌炎的患者的临床过程.
- 静脉外体膜氧化 (VA-ECMO) 的应用,用于机械循环支持.
- 静脉注射免疫球蛋白 (IVIg) 作为药理疗的使用.
主要成果:
- 早期VA-ECMO的成功实施为血液动力学提供了至关重要的支持.
- IVIg治疗有助于实现良好的临床结果.
- 患者在结合治疗方法后显著改善.
结论:
- 早期启动VA-ECMO是有利于管理危及生命的心肌炎疫苗接种后.
- 静脉注射免疫球蛋白治疗是实现这种疾病良好的临床结果的宝贵辅助.
- 这一案例强调了疫苗相关心肌炎的及时和积极的管理策略的重要性.
相关概念视频
Myocarditis II: Clinical Features and Diagnostic Tests
12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12
Myocarditis I: Introduction
9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Myocarditis III: Medical Management
7
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
7
Pericarditis I: Introduction
11
Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
11
Pericarditis III: Medical Management
13
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
13
Myocarditis IV: Nursing Management
13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13


